Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May act as a protease inhibitor to modulate the host immune response against tumor cells..
Showing 10 out of 19 products:
the SCCA-IgM determination could be helpful in predicting the response to therapy in patients with hepatocellular carcinoma.
Serum SCC (show CYP11A1 ELISA Kits)-Ag, hs-CRP (show CRP ELISA Kits), and CA-125 (show MUC16 ELISA Kits) were higher in recurrence cervical patients which could be potential biomarkers for predicting cervical cancer recurrence risk.
A close connection between SerpinB3 (show SERPINB3 ELISA Kits) and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.
Findings point to potential interest of squamous cell carcinoma antigen SERPINB3 (show SERPINB3 ELISA Kits)/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.
Serum SCCA2 (show SERPINB4 ELISA Kits) levels reflected disease severity and clinical type of atopic dermatitis. Serum SCCA2 (show SERPINB4 ELISA Kits) may thus be a relevant biomarker for atopic dermatitis.
role of SERPINB3 (show SERPINB3 ELISA Kits)/B4 mutations in immunotherapy response
Data show that in colorectal cancer SerpinB3 (show SERPINB3 ELISA Kits), COX-2 (show COX2 ELISA Kits) and beta-Catenin (show CTNNB1 ELISA Kits) are positively correlated and associated with more advanced tumor stage.
Results showed no correlation between gestational age and vaginal fluid SCC (show CYP11A1 ELISA Kits) levels. There was no significant difference in vaginal fluid SCC (show CYP11A1 ELISA Kits) levels between patients with premature rupture of membranes and those with control pregnant women.
Serum SCC (show CYP11A1 ELISA Kits)-Ag level was an important predictor for the cervical squamous carcinoma recurrence and prognosis.
Data indicate that serum tumor markers showed significant shorter 3-year progression-free survival (PFS) in higher levels compared to lower levels for S-CYFRA 21-1 (cytokeratin 19 (show KRT19 ELISA Kits) fragment), S-SCCA and S-CEA (show CEACAM5 ELISA Kits).
May act as a protease inhibitor to modulate the host immune response against tumor cells.
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3
, serpin B3
, squamous cell carcinoma antigen 1
, SCCA2/SCCA1 fusion protein
, peptidase inhibitor 11
, protease inhibitor (leucine-serpin)
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4
, serpin B4
, squamous cell carcinoma antigen 2